Day: November 13, 2025

LONDON, Nov. 13, 2025 (GLOBE NEWSWIRE) — Future, the global leader in specialist media, today announced the appointment of Michael Peralta as its new Chief Revenue Officer. Returning to the Group in this key leadership role, Peralta will oversee Future’s global commercial organisation spanning a vast portfolio of specialist media brands comprising B2C and B2B. Peralta, an experienced global media and technology executive, will join the Executive Leadership Team on 3 December 2025, reporting directly to Chief Executive Officer Kevin Li Ying. This strategic appointment comes as Future accelerates its focus on harnessing the power of AI, first-party data, and Retail Media Networks (RMN) to deliver greater value and future-ready solutions for its partners. “Future is investing in the best talent and leadership to supercharge...

Windtree and TESI signed a letter of intent for a combination of cash and securities of TESI to be paid to Windtree The companies were engaged in a potential environmental services deal for Windtree to acquire Titan Environmental Services, Inc. The executed agreement releases the parties from their reciprocal surviving obligations WARRINGTON, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on becoming a revenue generating company, announced that it has signed a letter of intent with TESI (OTC: TESI), an environmental services company, and Windtree will receive $7.5 million in cash and TESI securities. The companies were engaged on a potential acquisition of Titan Environmental Services, Inc., a waste management...

Infographic 1Infographic 1Infographic 2Infographic 2Infographic 3Infographic 3Infographic 4Infographic 4Infographic 5Infographic 5Infographics accompanying this announcement are available at  https://www.globenewswire.com/NewsRoom/AttachmentNg/ec2df2de-dfb1-4a07-8407-651fd33a4858 https://www.globenewswire.com/NewsRoom/AttachmentNg/9eb0fcd5-0106-4902-987f-4d7ff49ce32a https://www.globenewswire.com/NewsRoom/AttachmentNg/3aee281a-bd31-48c9-aae4-8122c1e3b6b1 https://www.globenewswire.com/NewsRoom/AttachmentNg/b74c8b60-de44-4c9d-8e1d-27451a40500a100% of the drill holes completed to date on Surebet have intersected substantial quartz-sulphide mineralization. VG-NE was observed in 83 drill holes out of 110 (or 76%) completed in 2025. 92% of the holes (355 out of 386) drilled to date at the Surebet...

CANTON, Conn., Nov. 13, 2025 (GLOBE NEWSWIRE) — Kelyniam Global, Inc. (OTC: KLYG), a leader in custom cranial and craniofacial implants, today announced it has secured an exclusive U.S. license from Evonik Industries AG to market VESTAKEEP® Fusion, a bi-calcium phosphate-infused PEEK material, for cranial, craniofacial, and maxillofacial implants. This agreement grants Kelyniam two years of exclusivity with the option for renewal upon mutual agreement. The license enhances Kelyniam’s regenerative product lineup by incorporating VESTAKEEP® Fusion’s osteoconductive properties, that promote human bone growth and integration. Distributed through Modern Plastics, a trusted long-term supplier of PEEK materials, this partnership leverages a proven relationship to ensure reliable access and supports Kelyniam’s growth...

RELEASE Paris, November 13, 2025 INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES COMPRISING THE SHARE CAPITALIn accordance with the provisions of Article L. 233-8 of the French Commercial Code (Code de commerce) and Article 223-16 of the General Regulations of French Autorité des Marchés Financiers (AMF), Hermès international publishes each month, before the 15th day of the following month, the total number of voting rights and the number of shares comprising the share capital if they have varied from those previously published.Date Total number of shares Total number of theoretical voting rights (including treasury stock) Total number of effective voting rights (exercisable at shareholders’ meetings) Publications31 October 2025 105 569 412 179 251 764 178 518 628 13 November 202530 September 2025 105 569 412 179 543...

Verkkokauppa.com Oyj, Stock Exchange Release, 13 November 2025 at 07:00 p.m. EET Verkkokauppa.com Oyj: Acquisition of own shares on 13 November 2025Date 13 November 2025  Exchange transaction Buy  Share trading code VERK  Amount, shares 15,306  Average price/share (EUR) 4.0152  Total cost (EUR) 61,456.65  After the acquisitions Verkkokauppa.com Oyj holds a total of  248,736 treasury shares. On behalf of Verkkokauppa.com Oyj Danske Bank A/S, Finland Branch Antti Väliaho                        Jonathan Nyberg For more information, please contact: Jesper Blomster, CFOVerkkokauppa.com Oyjjesper.blomster@verkkokauppa.com Verkkokauppa.com is an e-commerce pioneer that stands passionately on the customer’s side. Verkkokauppa.com accelerates the transition of commerce to online with Finland’s fastest deliveries and ultimate...

Paris, 13 November 2025 Capitalised terms used herein shall have the meaning specified for such terms in the Caisse Française de Financement Local base prospectus to the €75,000,000,000 Euro Medium Term Note Programme dated 10 June 2025 (the “Base Prospectus”). Caisse Française de Financement Local has decided to issue on 17 November 2025 – Euro 150,000,000 Fixed Rate Obligations Foncières due 17 May 2039 to be assimilated upon listing and form a single series with the existing Euro 500,000,000 Fixed Rate Obligations Foncières due 17 May 2039 issued on 17 May 2024, the existing Euro 250,000,000 Fixed Rate Obligations Foncières due 17 May 2039 issued on 22 May 2024 and the existing Euro 150,000,000 Fixed Rate Obligations Foncières due 17 May 2039 issued on 13 November 2025. The Base Prospectus dated 10 June 2025 approved by the Autorité...

31,000-square-foot site expands Legend’s U.S. R&D footprint and strengthens its position as a global leader in cell therapy innovation The facility will support CAR-T R&D in potential oncology and immunology indicationsA Media Snippet accompanying this announcement is available by clicking on this link. SOMERSET, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) — Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a U.S.-based global leader in cell therapy, today announced the official opening and ribbon cutting of its new, state-of-the-art research and development (R&D) facility in Philadelphia, Pennsylvania. Located at 2300 Market Street, the 31,000-square-foot facility is now fully operational and will support Legend’s expanding pipeline of next-generation cell therapies. The site features cutting-edge laboratories...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Americas Gold and Silver Corporation (TSX: USA) (NYSE American: USAS) (“Americas” or the “Company”) is pleased to announce that as a result of strong investor demand, the Company has amended its agreement with a syndicate of underwriters led by Canaccord Genuity Corp. and BMO Capital Markets (collectively, the “Underwriters”) to increase the size of its previously announced “bought deal” private placement to aggregate gross proceeds of US$115,000,000. The Offering (as defined herein) shall consist of 28,750,000 common shares of the Company (the “Common Shares”) at a price of US$4.00 per Common Share (the “Offering”). The Company has also granted the Underwriters an option to purchase up to an additional...